Criteria for determining significance:
If the null hypothesis is rejected and the alternative hypothesis is accepted.
If the null hypothesis is accepted and the alternative hypothesis is rejected.
F = 206.87
Based on the calculations, the value was 206.87, more significant than 1.98. These results show that rejection means simultaneously patient and CRM participation affects value co-creation.
Partial Hypothesis Testing
Partial Influence of Patient Participation in Value Co-Creation
The results of the partial test of patient participation in the value of co-creation in outpatients at the Polyclinic of Obstetrics and Gynaecology of the Islamic Hospital of Tasikmalaya obtained the coefficient of patient participation pathway (X1) to the value of co-creation (Y) was 0.237, the value was 3.276 and the value with a significance level of () 5% was 1.65. A value more significant than the value indicates that it is rejected, which means that patient participation affects the co-creation value with a pathway coefficient of 0.237, where each increase in patient participation will increase the co-creation value by 0.237. The study's results follow previous research by Hossain et al. (2019), which explained that patient participation affects the creation of patient value.
Partial Impact of CRM on Value Co-Creation
The results of the partial test of CRM on the co-creation value obtained the coefficient of CRM path (X2) to the co-creation value (Y) was 0.342, the value was 5.117, and the value with a significance level () of 5% was 1.65. A value more significant than the value indicates that it is rejected, which means that the CRM affects the co-creation value by a path coefficient of 0.342, where each increase in CRM will increase the co-creation value by 0.342.
The Effect of Patient Participation, CRM, and Value Co-Creation on Loyalty
